SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-12-026055
Filing Date
2012-05-04
Accepted
2012-05-04 09:03:47
Documents
1
Period of Report
2012-06-19
Effectiveness Date
2012-05-04

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A v311887_def14a.htm DEF 14A 365164
  Complete submission text file 0001144204-12-026055.txt   366231
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: DEF 14A | Act: 34 | File No.: 000-25169 | Film No.: 12812038
SIC: 2834 Pharmaceutical Preparations